Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07540988
PHASE3

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

This study is open to adults with fibrosing interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis (IPF). People can join the study if they have been diagnosed with this condition within the last 3 years and are at risk of developing progressive pulmonary fibrosis (PPF). The purpose of this study is to find out whether a medicine called nerandomilast helps people with fibrosing interstitial lung disease who may be at risk for their disease getting worse. Participants are put into 2 groups randomly, which means by chance. One group takes nerandomilast tablets, and the other group takes placebo tablets. Placebo tablets look like nerandomilast tablets but do not contain any medicine. Nerandomilast is a type of medicine that may help reduce lung function decline and slow disease progression. Participants are in the study for up to about 2 years and 4 months. During this time, they visit the study site regularly. Doctors regularly test lung function using methods like spirometry to measure forced vital capacity (FVC, maximum amount of air a participant can blow out after taking a deep breath) and DLCO (diffusing capacity of the lungs for carbon monoxide; it estimates how well oxygen moves from the lungs into the blood). Additionally, high-resolution computed tomography (HRCT) is performed to monitor how the lung condition is changing over time. The results are compared between the groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.

Official title: A Double-blind, Randomized, Placebo-controlled Trial Investigating the Efficacy and Safety of Nerandomilast Over at Least 52 Weeks in Patients With Fibrosing Interstitial Lung Disease at Risk for Disease Progression (FIBRONEER-ACT)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

466

Start Date

2026-08-28

Completion Date

2028-12-12

Last Updated

2026-06-02

Healthy Volunteers

No

Interventions

DRUG

Nerandomilast

Nerandomilast

DRUG

Placebo matching nerandomilast

Placebo matching nerandomilast

Locations (100)

University of Alabama at Birmingham

Birmingham, Alabama, United States

University of Southern California

Los Angeles, California, United States

Clinical Research Specialists LLC - Kissimmee

Kissimmee, Florida, United States

Lakeland Regional Medical Center - Lakeland

Lakeland, Florida, United States

Advanced Pulmonary Research Institute

Loxahatchee Groves, Florida, United States

Avanza Medical Research Center

Pensacola, Florida, United States

University of Kansas Medical Center

Kansas City, Kansas, United States

University of Minnesota

Minneapolis, Minnesota, United States

Coastal Carolina Health Care, P.A. Pulmonary and Sleep Medicine

New Bern, North Carolina, United States

Southeastern Research Center-Winston-Salem-61365

Winston-Salem, North Carolina, United States

Temple University Hospital

Philadelphia, Pennsylvania, United States

Lowcountry Lung and Critical Care

Charleston, South Carolina, United States

Clinical Trials Center of Middle Tennessee, LLC

Franklin, Tennessee, United States

Baylor University Medical Center

Dallas, Texas, United States

University of Utah Health Sciences Center

Salt Lake City, Utah, United States

Instituto de Medicina Respiratoria (IMeR)

Alberdi Sur, Argentina

Hospital Aleman

CABA, Argentina

Fundacion NIBA Neurologia Infantil Buenos Aires

CABA, Argentina

Consultorios Médicos del Buen Ayre

Capital Federal, Argentina

Instituto Ave Pulmo - Fundacion Enfisema

Mar del Plata, Argentina

INSARES

Mendoza, Argentina

Fundacion Innovaciencia

Rosario, Argentina

UZ Leuven

Leuven, Belgium

Centre Hospitalier Universitaire de Liège

Liège, Belgium

Roeselare - HOSP AZ Delta

Roeselare, Belgium

CLARE - Clinica de Pneumologia

Goiânia, Brazil

Irmandade da Santa Casa de Misericórdia de Porto Alegre

Porto Alegre, Brazil

INCOR e Hospital das Clínicas da Universidade de São Paulo

São Paulo, Brazil

Kelowna Respirology & Allergy Research

Kelowna, British Columbia, Canada

Toronto General Hospital

Toronto, Ontario, Canada

Beijing Chao-Yang Hospital

Beijing, China

The Second Xiangya Hospital Of Central South University

Changsha, China

West China Hospital, Sichuan University

Chengdu, China

People's Hospital of Sichuan Province

Chengdu, China

First Affiliated Hospital of Guangzhou Medical University

Guangzhou, China

Zhejiang Hospital

Hangzhou, China

Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine

Hangzhou, China

Nanjing Drum Tower Hospital

Nanjing, China

Shanghai Chest Hospital

Shanghai, China

Shanghai Pulmonary Hospital

Shanghai, China

The First Affiliated Hospital of Soochow University

Suzhou, China

Tianjin Medical University General Hospital

Tianjin, China

Wuhan Union Hospital

Wuhan, China

Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T

Wuhan, China

Wuxi People's Hospital

Wuxi, China

Second Affiliated Hospital of Xi'an JiaoTong University

Xi'an, China

General Hospital of Ningxia Medical University

Yinchuan, China

Henan Provincial People's Hospital

Zhengzhou, China

HYKS Keuhkosairauksien tutkimusyksikkö

Helsinki, Finland

Turku University Hospital / TYKS

Turku, Finland

Charité - Universitätsmedizin Berlin

Berlin, Germany

Vivantes Netzwerk für Gesundheit GmbH

Berlin, Germany

Universitätsklinikum Bonn AöR

Bonn, Germany

Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH

Essen, Germany

Klinikum Region Hannover GmbH

Hanover, Germany

Medizinische Hochschule Hannover

Hanover, Germany

Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg

Heidelberg, Germany

Lungenfachklinik Immenhausen

Immenhausen, Germany

Klinikum der Universität München AÖR

München, Germany

Robert-Bosch-Krankenhaus GmbH

Stuttgart, Germany

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Catania, Italy

Ospedale Colonnello D Avanzo

Foggia, Italy

Ospedale G.B. Morgagni

Forlì, Italy

Ospedale Classificato San Giuseppe

Milan, Italy

A.O. San Gerardo di Monza

Monza, Italy

Azienda Ospedaliera Universitaria di Padova

Padova, Italy

Pol. Universitario Tor Vergata

Roma, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, Italy

Tosei General Hospital

Aichi, Seto, Japan

National Hospital Organization Kyushu Medical Center

Fukuoka, Fukuoka, Japan

Hiroshima Prefectural Hospital

Hiroshima, Hiroshima, Japan

Hiroshima University Hospital

Hiroshima, Hiroshima, Japan

Sapporo Medical University Hospital

Hokkaido, Sapporo, Japan

Kanagawa Cardiovascular and Respiratory Center

Kanagawa, Yokohama, Japan

Kindai University Hospital

Osaka, Sakai, Japan

Hamamatsu University Hospital

Shizuoka, Hamamatsu, Japan

Tokushima University Hospital

Tokushima, Tokushima, Japan

Juntendo University Hospital

Tokyo, Bunkyo-ku, Japan

Keio University Hospital

Tokyo, Shinjuku-ku, Japan

National Center for Global Health and Medicine

Tokyo, Shinjuku-ku, Japan

Centro de Investigacion Integral MEDIVEST S.C

Chihuahua City, Mexico

Hospital Universitario Dr Jose Eleuterio Gonzalez

Monterrey, Mexico

St. Antonius Ziekenhuis

Nieuwegein, Netherlands

Erasmus Medisch Centrum

Rotterdam, Netherlands

Inje University Busan Paik Hospital

Busan, South Korea

Inje University Haeundae Paik Hospital

Busan, South Korea

Seoul National University Bundang Hospital

Seongnam, South Korea

Seoul National University Hospital

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

Hospital Universitari Vall d'Hebron

Barcelona, Spain

Hospital de Galdakao

Galdakao, Spain

Hospital General de Granollers

Granollers, Spain

Hospital Universitari de Bellvitge

Hospitalet Llobregat, Spain

Kaohsiung Veterans General Hospital

Kaohsiung City, Taiwan

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, Taiwan

China Medical University Hospital

Taichung, Taiwan

Taichung Veterans General Hospital

Taichung, Taiwan

National Taiwan University Hospital

Taipei, Taiwan

Taipei Veterans General Hospital

Taipei, Taiwan